Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Puma Biotechnology
(NASDAQ:PBYI)
Intraday
$5.20
0.37
[7.66%]
After-Hours
$5.20
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$5.20
0.37
[7.66%]
At close: Apr 24
$5.20
0
[0.00%]
PreMarket: 8:44AM EDT
Get Report
Watch
Q1 2024 Earnings in 7 days from now on Thu May 2nd, after the market close
Conference call scheduled in 7 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Puma Biotechnology Stock (NASDAQ:PBYI)
Puma Biotechnology Stock (NASDAQ: PBYI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, March 20, 2024
Puma Biotechnology Announces FDA Allowance To Proceed Under IND For Alisertib In HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
Benzinga Newsdesk
-
Mar 20, 2024, 8:32AM
Tuesday, March 19, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Mar 19, 2024, 1:35PM
Monday, March 18, 2024
Watching Puma Biotechnology; Traders Circulate Rumor, "Puma Has Been Dismissed As A Plaintiff In Its Case Against AstraZeneca Alleging That Tagrisso Infringes Its Patents Citing Lack Of Standing"
Benzinga Newsdesk
-
Mar 18, 2024, 2:07PM
Friday, March 01, 2024
HC Wainwright & Co. Maintains Buy on Puma Biotechnology, Lowers Price Target to $7
Benzinga Newsdesk
-
Mar 1, 2024, 2:53PM
Thursday, February 29, 2024
Puma Biotechnology Sees FY24 Net Product Revenue $183M-$190M
Benzinga Newsdesk
-
Feb 29, 2024, 4:43PM
Puma Biotechnology Sees Q1 2024 Net Product Revenue $38M-$40M
Benzinga Newsdesk
-
Feb 29, 2024, 4:42PM
Puma Biotechnology shares are trading lower after the company reported mixed Q4 financial results.
Benzinga Newsdesk
-
Feb 29, 2024, 4:39PM
Puma Biotechnology Q4 2023 Adj EPS $0.310 Beats $0.300 Estimate, Sales $72.200M Miss $73.550M Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 4:15PM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Wednesday, February 14, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 14, 2024, 12:31PM
Tuesday, February 13, 2024
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $8 Price Target
Benzinga Newsdesk
-
Feb 13, 2024, 12:29PM
Puma Biotechnology Initiates ALISCA-Lung1 Phase II Trial Of Alisertib In Small Cell Lung Cancer
Benzinga Newsdesk
-
Feb 13, 2024, 8:33AM
Monday, December 11, 2023
Puma Biotechnology Announces Phase II Clinical Trial Design For Alisertib In HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer; Plans To Initiate Trial In H2 2024
Benzinga Newsdesk
-
Dec 11, 2023, 8:32AM
Friday, November 10, 2023
Puma Biotechnology Board Member Trades Company's Stock
Benzinga Insights
-
Nov 10, 2023, 10:03AM
Thursday, November 02, 2023
Puma Biotechnology Sees FY23 Revenue $206M-$209M Vs $236.23M Est
Benzinga Newsdesk
-
Nov 2, 2023, 6:01PM
Puma Biotechnology Sees Q4 2023 Product Revenue $56M-$59M Vs $71.45M Est
Benzinga Newsdesk
-
Nov 2, 2023, 6:00PM
Puma Biotechnology Q3 2023 Adj EPS $0.17 Beats $0.08 Estimate, Sales $56.10M Miss $57.95M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 4:18PM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Monday, October 16, 2023
Puma Biotechnology Presented Findings From A Phase I/II Study Of Alisertib And Pembrolizumab For Rb-Deficient Head And Neck Squamous Cell Carcinomas At The 2023 AACR-NCI-EORTC Molecular Targets And Cancer Therapeutics Meeting
Benzinga Newsdesk
-
Oct 16, 2023, 2:25AM
Thursday, September 21, 2023
Puma Biotechnology Secures FDA Orphan Drug Designation For Alisertib For The Treatment Of Small Cell Lung Cancer
Benzinga Newsdesk
-
Sep 21, 2023, 4:11PM
Wednesday, September 20, 2023
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $8 Price Target
Benzinga Newsdesk
-
Sep 20, 2023, 6:35AM
Tuesday, August 08, 2023
Puma Biotechnology Announces FDA Clearance Of IND For Alisertib In Small Cell Lung Cancer
Benzinga Newsdesk
-
Aug 8, 2023, 8:38AM
Friday, August 04, 2023
Puma Biotechnology shares are trading higher after the company reported better-than-expected Q2 financial results.
Benzinga Newsdesk
-
Aug 4, 2023, 10:56AM
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $8 Price Target
Benzinga Newsdesk
-
Aug 4, 2023, 8:20AM
Thursday, August 03, 2023
Puma Biotechnology Sees FY23 Revenue $205M-$210M Vs $232.31M Est
Benzinga Newsdesk
-
Aug 3, 2023, 6:05PM
Puma Biotechnology Sees Q3 Revenue $51M-$53M Vs $60.49M Est
Benzinga Newsdesk
-
Aug 3, 2023, 6:04PM
Puma Biotechnology Q2 Adj EPS $0.10 Beats $0.07 Estimate, Sales $54.60M Beat $51.37M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 4:35PM
Earnings Scheduled For August 3, 2023
Benzinga Insights
-
Aug 3, 2023, 6:59AM
Monday, July 24, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jul 24, 2023, 9:06AM
Thursday, July 20, 2023
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 20, 2023, 8:04AM
Monday, June 05, 2023
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $8 Price Target
Benzinga Newsdesk
-
Jun 5, 2023, 6:34AM
Friday, May 05, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
May 5, 2023, 1:31PM
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $8 Price Target
Benzinga Newsdesk
-
May 5, 2023, 7:39AM
Thursday, May 04, 2023
Puma Biotechnology: Q1 Earnings Insights
Benzinga Insights
-
May 4, 2023, 4:25PM
Puma Biotechnology Q1 Adj. EPS $0.09 Beats $(0.07) Estimate, Sales $52.80M Beat $49.63M Estimate
Benzinga Newsdesk
-
May 4, 2023, 4:24PM
Earnings Scheduled For May 4, 2023
Benzinga Insights
-
May 4, 2023, 6:34AM
Tuesday, April 18, 2023
Puma Biotechnology Awarded $8,562,530 Contract From Department Of Veterans Affairs For Pharmaceutical Preparation Manufacturing
Happy Mohamed
-
Apr 18, 2023, 3:30PM
Thursday, March 30, 2023
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Mar 30, 2023, 12:43PM
Tuesday, March 14, 2023
Puma Biotechnology Announces Publication Of Phase II Clinical Trial Of Alisertib In JAMA Oncology
Happy Mohamed
-
Mar 14, 2023, 8:31AM
Monday, March 06, 2023
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $8 Price Target
Benzinga Newsdesk
-
Mar 6, 2023, 6:16AM
Friday, March 03, 2023
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Mar 3, 2023, 1:20PM
Puma Biotechnology shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results.
Michael Horton
-
Mar 3, 2023, 10:48AM
Thursday, March 02, 2023
Puma Biotechnology Sees Q1 Net Product Revenue $43M-$46M; Sees FY23 Net Product Revenue $205M-$210M
Michael Horton
-
Mar 2, 2023, 4:10PM
Puma Biotechnology Q4 Adj. EPS $(0.07) Misses $0.01 Estimate, Sales $65.70M Beat $57.06M Estimate
Michael Horton
-
Mar 2, 2023, 4:09PM
Earnings Scheduled For March 2, 2023
Benzinga Insights
-
Mar 2, 2023, 4:37AM
Wednesday, February 01, 2023
Puma Biotechnology's NERLYNX Included In NCCN Clinical Practice Guidelines For The Treatment Of Breast Cancer With A HER2 Mutation
Happy Mohamed
-
Feb 1, 2023, 8:35AM
Monday, December 26, 2022
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Dec 26, 2022, 12:32PM
Friday, December 16, 2022
Puma Biotechnology Says Effective Dec 13 Co., Wyeth Entered Into Settlement And License Agreement With Sandoz
Michael Horton
-
Dec 16, 2022, 4:21PM
Monday, November 28, 2022
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
Lisa Levin
-
Nov 28, 2022, 5:09AM
Friday, November 25, 2022
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Nov 25, 2022, 12:31PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch